Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Target Genes for Diagnosis and Prognosis of AML Using a Custom-Design Microarray

NCT00897182 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.

NCT NCT00897182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00897182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Target Genes for Diagnosis and Prognosis of AML Using a Custom-Design Microarray
Lead sponsor
Alliance for Clinical Trials in Oncology
Phase
Observational
Overall status
Completed
Start date
May 31, 2008
Completion date
March 31, 2014
Enrollment
96 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia